CLINICAL AND PATHOGENETIC FEATURES OF CARDIOVASCULAR PATHOLOGY IN ELDERLY PATIENTS AND SENILE AGE (Literature review)
Keywords:
old age, senile age, cardiovascular diseases, coronary heart disease, atherosclerosis, heart rhythm disordersAbstract
Throughout the world, especially in developed countries, the absolute number and proportion of elderly (>65 years) and senile (>75 years) people are increasing. Demographers and sociologists predict that the aging of the population will continue, and by 2025 the number of people aged 60 and older will increase fivefold. One important reason for this, along with declining fertility rates, is improved treatment of cardiovascular disease, which is the leading cause of death among the elderly. The most common cardiovascular disorders in the elderly are arterial hypertension, coronary heart disease, and chronic heart failure. It was widely believed that only symptomatic treatment of cardiovascular disease in the elderly and older adults was necessary until recently. Drug intervention had little effect on the prognosis of life at this age. Meanwhile, large clinical trials convincingly testify that the age of patients is not an obstacle to active medical and surgical treatment of many CVDs. However, it is necessary to consider the peculiarities of CVD treatment in elderly and senile patients.
References
Benvenuto LJ, Krakoff LR Morbidity and mortality of orthostatic hypotension: implications for cardiovascular disease // Am management. J. Hypertens. 2011 Vol. 24, No. 2. P. 135-144.
Bergman H., Ferrucci L., Guralnik J., et al. Frailty: an emerging research and clinical paradigm - issues and controversies // J. Gerontol. A biol. sci. Med. sci. 2007 Vol. 62, No. 7. P. 731-737.
Benetos A., Rossignol P., Cherubini A. et al. Polypharmacy in the aging patient: management of hypertension in octogenarians // JAMA. 2015. Vol. 314. P. 170-180.
8. Blacher J., Halimi JM, Hanon O. et al.; French Society of Hypertension. Management of hypertension in adults: the 2013 French Society of Hypertension guidelines // Fundam. Clin. Pharmacol. 2014. Vol. 28. P. 1-9.
Bouhanick B., Meliani S., Doucet J. et al. Gerodiab Study group. Orthostatic hypotension is associated with more severe hypertension in elderly autonomous diabetic patients from the French Gerodiab study at inclusion // Ann. cardiol. Angelol. (Paris). 2014. Vol. 63, No. 3. P. 176-182.
Cesari M., Gambassi G., Van Kan GA et al. The frailty phenotype and the frailty index: different instruments for different purposes // Age Aging. 2014. Vol. 43, N 1. P. 10-12.
Abdukadirova N.M., Kurbanov N.B., Tulaboeva G.M., Talipova Yu.Sh., Sagatova Kh.M. Therapy of chronic heart failure with preserved left ventricular ejection fraction in older patients. // “Journal of Theoretical and Clinical Medicine”, No. 1, 2022 From 57-63 .
Aronow WS, Fleg JL, Pepine CJ et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension // J. Am. soc. hypertens. 2011 Vol. 5. P. 259-352. doi: 10.1016/j. jash.2011.06.001.
Beckett NS, Peters R., Fletcher AE et al.; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older // N. Engl. J. Med. 2008 Vol. 358, No. 18. P. 1887-1898.
Benetos A., Bulpitt CJ, Petrovic M. et al. An Expert Opinion from the European society of hypertension - European union geriatric medicine society Working group on the management of hypertension in very old, frail subjects // Hypertension 2016. Vol. 67. P. 820-825. doi: 10.1161/HYPERTENSI0NAHA.115.07020.
Collard RM, Boter H., Schoevers RA, Oude Voshaar RC Prevalence of frailty in community-dwelling older persons: a systematic review // J. Am. Geriatr. soc. 2012. Vol. 60, No. 8. P. 1487-1492.
Fried LP, Ferrucci L., Darer J. et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care // J. Gerontol. A biol. sci. Med. sci. 2014. Vol. 59, No. 3. P. 255-263.
Fisher A/L. Just what defines frailty? // J. Am. Geriatr. soc. 20 1 7. Vol. 53, No. 12. P. 2229-2230.
Finucane C., O’Connell MD, Fan CW et al. Age-related normative changes in phasic orthostatic blood pressure in a large population study: findings from the Irish Longitudinal Study on Aging (TILDA) // Circulation. 2014. Vol. 130, No. 20. P. 1780-1789.
Stavenow L., Hedblad B. et al. Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project) // Eur. Heart J. 2010. Vol. 31. P. 85-91.
Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia // Lancet Neurol. 2005 Vol. 4. P. 487-99.
Shamliyan T., Talley KM, Ramakrishnan R., Kane RL Association of frailty with survival: a systematic literature review // Ageing Res. Rev. 2013. Vol. 12, No. 2. P. 719-736.
Sabayan B., Oleksik AM, Maier AB et al. High blood pressure and resilience to physical and cognitive decline in the oldest: the Leiden 85-plus Study // J. Am. Geriatr. soc. 2012. Vol. 60. P. 2014-2019.
Senn N., Monod S. Development of a comprehensive approach for the early diagnosis of geriatric syndromes in general practice // Front. Med. (Lausanne). 2015. Vol. 2. P. 78.
24 . Talipov R.M., Tulabaeva G.M., Sagatova H.M., Nurmetov H.T., Khudaiberganova N.Kh. Features of comorbidity in elderly patients with myocardial infarction Uzbek medical journal 2021 Volume 2. No. 3.
Talipova Yu.Sh., Nuralieva D.M., Tulaboeva G.M., Otamirzaev N.R., Kamalov B.B., Kasimova G.M., Kasimova M.S. The use of atorvastatin in the complex therapy of coronary heart disease with arterial hypertension in older patients // Journal of Theoretical and Clinical Medicine, No. 3, 2020. P 69-73
Taekema DG, Maier AB, Westendorp RG, de Craen AJ Higher blood pressure is associated with higher handgrip strength in the oldest old // Am. J. Hypertens. 2011 Vol. 24. P. 83-89.
Khokhlov R.A., Gaidashev A.E., Akhmedzhanov N.M. Predictors of atherosclerotic lesions of the arteries of the extremities according to cardioangiological screening of the adult population. Rational. pharmacotherapy in cardiology. 2015. V. 11, No. 5. S. 470-476.
Wilhelm-Leen ER, Hall YN, Tamura MK et al. Frailty and chronic kidney disease: the third National Health and Nutrition Evaluation Survey // Am. J. Med. 20 1 9. Vol. 122, No. 7. P. 664-671.
Woo J., Yu R., Wong M. et al. Frailty Screening in the Community Using the FRAIL Scale // J. Am. Med. Dir. Assoc. 2015. Vol. 16, No. 5. P. 412-419.
Weber MA, Schiffrin EL, White WB et al. Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension // J. Hypertens. 2014. Vol. 32. P. 3-15.
Warwick J., Falaschetti E., Rockwood K. et al. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over // BMC Med. 2015. Vol. 13. P. 78.
Tulaboeva GM, Talipova Yu.Sh., Sagatova XM, Abdukodirova NM, Kosimova MA, Xusanov AA Study of the effectiveness of rosuvastatin in coronary heart disease and diabetes mellitus in older people. Nazariy va clinic Tibbiet magazine 2022 Tashkent No. 1 . From 60-66.
Tulaboeva G.M., Talipova Yu.Sh., Sagatova Kh.M., Azizova F.F., Nuralieva D.M. Features of electrocardiographic changes in the elderly / Educational and methodological manual, Tashkent 2020, 103 pages.
Tulaboeva G.M. , Talipova Yu.Sh. , Sagatova Kh.M. , Abdukodirova N.M., Kosimova M.A. , Khusanov A.A. , Kasimova M.S. The use of rosuvastatin in older patients age with coronary heart disease and diabetes . NAZARIY va KLINIK TIBBIYOT JURNALI No. 1 2022, “Journal of Theoretical and Clinical Medicine”, No. 1, 2022, pp . 62-67 .
Tulaboeva G.M., Sagatova Kh.M., Talipova Yu.Sh. Comorbidity of depressive disorders and CVD. Monograph . Printed at: see last page ISBN: 978-620-3-04096-8 , 2020 y . 127 r.
